Detalles de la búsqueda
1.
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Oncologist
; 29(2): 142-150, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589219
2.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407342
3.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405085
4.
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 383(24): 2345-2357, 2020 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955174
5.
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
N Engl J Med
; 382(22): 2091-2102, 2020 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343890
6.
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Lancet Oncol
; 23(10): 1297-1307, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063830
7.
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(3): 393-405, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157830
8.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(9): 1133-1144, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055304
9.
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC Cancer
; 22(1): 1213, 2022 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36434554
10.
Post Hoc Health-Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies.
Oncologist
; 26(7): e1179-e1188, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33904646
11.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860937
12.
Metronomic cyclophosphamide induces regulatory T cells depletion and PSA-specific T cells reactivation in patients with biochemical recurrent prostate cancer.
Int J Cancer
; 147(4): 1199-1205, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31749145
13.
Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial.
Oncologist
; 25(5): e843-e851, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32212354
14.
Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation.
Cancer Immunol Immunother
; 69(10): 1947-1958, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676716
15.
Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol.
Health Qual Life Outcomes
; 17(1): 25, 2019 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30717745
16.
In Reply: Randomized Studies Are Needed to Improve Knowledge of Nutritional Interventions for Advanced Cancer Patients.
Oncologist
; 26(3): e519-e520, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33426725
17.
Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer.
Int J Gynecol Cancer
; 26(2): 261-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26807562
18.
In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?
Oncologist
; 20(4): 344-50, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25795632
19.
Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.
PLoS One
; 19(5): e0302548, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38728337
20.
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Ther Adv Urol
; 16: 17562872241229876, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425504